News

The new production line will produce Paclitaxel, a chemotherapy agent inhibiting proliferation of cancer cells used in the treatment of patients with breast, ovarian and non-small cell lung

The calcium in Xtra-Cal helps maintain strong, healthy bones and teeth while the magnesium and vitamin D present in the product enable improved calcium absorption. Xtra-Cal consumption will

According to the study data, 74% (28 out of 38) of patients who were treated with Incivek combination therapy had undetectable hepatitis C virus (HCV RNA) 12 weeks

Surfaxin (lucinactant intratracheal suspension) is a synthetic, peptide-containing surfactant, indicated for use in premature infants at high risk for RDS. Discovery Labs chief executive officer and chairman of

Amitiza is indicated for the treatment of chronic idiopathic constipation and for IBS-C. The open-label extension Phase 3 study was conducted by Takeda Pharmaceuticals USA, and Sucampo Pharmaceuticals

The LyoCell technology allows for the solubilization, stabilization, and delivery of a wide range of compounds – both small and large molecule. As per the agreement, PSI obtains

Marshall Edwards is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. Marshall Edwards president and chief executive officer Daniel Gold expressed satisfaction

The new product called Diabetic Vision Formula was developed to help protect against potential vision problems associated with diabetic retinopathy, a condition that may lead to blindness and

The application was not approved by FDA because the pre-specified analysis of the primary endpoint in the study (DACO-016) did not demonstrate statistically significant superiority of Dacogen over